⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
CAPLIPOINT - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.0
| Stock Code | CAPLIPOINT | Market Cap | 13,705 Cr. | Current Price | 1,803 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 39.2 | Book Value | 243 ₹ | Dividend Yield | 0.33 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,859 ₹ | DMA 200 | 1,963 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.05 % | PAT Qtr | 103 Cr. | PAT Prev Qtr | 85.9 Cr. |
| RSI | 49.6 | MACD | -33.7 | Volume | 36,985 | Avg Vol 1Wk | 63,250 |
| Low price | 1,551 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.78 | Debt to equity | 0.00 |
| 52w Index | 29.8 % | Qtr Profit Var | -2.98 % | EPS | 46.0 ₹ | Industry PE | 29.1 |
📊 Technical Analysis
- Chart Patterns: CAPLIPOINT is consolidating after a decline from its 52-week high of 2,397 ₹, currently stabilizing near 1,803 ₹.
- Moving Averages: Price (1,803 ₹) is below both 50 DMA (1,859 ₹) and 200 DMA (1,963 ₹), showing short-term and medium-term weakness.
- RSI: At 49.6, neutral — no strong momentum signal.
- MACD: Negative (-33.7), indicating bearish momentum.
- Bollinger Bands: Price near mid-band, suggesting consolidation with limited volatility.
- Volume Trends: Current volume (36,985) below 1-week average (63,250), showing weak participation.
📈 Momentum & Signals
- Short-term Momentum: Weak due to negative MACD and low volume.
- Support Levels: 1,770 ₹ (near-term), 1,551 ₹ (major support).
- Resistance Levels: 1,860 ₹ (50 DMA), 1,963 ₹ (200 DMA).
- Optimal Entry Zone: 1,750–1,780 ₹ (close to support).
- Optimal Exit Zone: 1,850–1,900 ₹ (near resistance).
- Trend Status: Consolidating with bearish bias.
✅ Positive
- Strong ROCE (28.6%) and ROE (22%) highlight efficient capital usage.
- Debt-free balance sheet (Debt-to-equity 0.00) reduces financial risk.
- EPS of 46 ₹ supports long-term earnings visibility.
⚠️ Limitation
- High P/E (39.2) compared to industry PE (29.1), suggesting overvaluation.
- PEG ratio of 1.78 indicates limited growth relative to valuation.
- Quarterly profit variation (-2.98%) shows recent earnings slowdown.
📉 Company Negative News
- Recent decline in quarterly profit raises concerns about near-term growth.
- DII holdings decreased (-0.05%), showing reduced domestic institutional confidence.
📈 Company Positive News
- FII holdings increased (+0.07%), showing foreign investor interest.
- Strong fundamentals with high ROCE and ROE despite short-term weakness.
🏭 Industry
- Pharmaceutical sector supported by global demand and healthcare expansion.
- Industry PE at 29.1 vs stock PE at 39.2 — stock trades at premium valuation.
🔎 Conclusion
- CAPLIPOINT is consolidating with short-term bearish signals but strong long-term fundamentals.
- Best entry near 1,750–1,780 ₹, exit near 1,850–1,900 ₹ unless breakout above 1,963 ₹ occurs.
- Medium-term outlook cautious due to valuation premium and recent earnings slowdown.